(Community Matters) NYT: an extraordinarily poignant story demonstrating the ethical dillemas of clinical trials – is it right to withhold a promising drug from patients whose lives it could save, in order to measure against a control group?
both in the clinical trials – Thomas (left) is receiving the drug, his cousin Brandon (right) was in the control group
.
I find myself unable to form a detached opinion – I think immediately of Michael Mitchell’s lymphoma and Doug Ulman’s melanoma (both in remission) and wouldn’t want to settle for any arguments if eithers’ cancer returned. (Not to mention the avalanche of names and types of cancer that floods into my head thinking just a minute longer.)
Community Matters 